Showing results (281-290 of 391) with videos related to

Sort By:
Pageof 40
NPJ Breast Cancer|December 8, 2017
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breastSalvatore Piscuoglio, Charlotte K Y Ng, Felipe C Geyer, et al.
British Journal of Cancer|August 26, 2020
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumoursChristophe Le Tourneau, Jean-Pierre Delord, Nuria Kotecki, et al.
Histopathology|September 9, 2015
Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical managementEmad A Rakha, Sunil Badve, Vincenzo Eusebi, et al.
Cancer Research|November 13, 2012
Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancerVirginie Maire, Fariba Némati, Marion Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2017
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their MetastasesCharlotte K Y Ng, Francois-Clement Bidard, Salvatore Piscuoglio, et al.
Cell Reports. Medicine|January 10, 2026
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancerPaul Cottu, Yann Kieffer, Jerome Lemonnier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancerMichel Wassef, Armelle Luscan, Setareh Aflaki, et al.
Histopathology|February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutationsDaniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Oncogene|August 2, 2018
Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia functionAlessia Castagnino, Antonio Castro-Castro, Marie Irondelle, et al.
Cell Stem Cell|December 18, 2014
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasisBenjamin G Cuiffo, Antoine Campagne, George W Bell, et al.
Pageof 40